Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of SGMO will decline by -2.46% over the next 2 Weeks and hit $0.42 by Tuesday, January 13, 2026. In that time frame, SGMO's share price is expected to range between $0.38 and $0.46.
BearishAverageBullishSGMO shares rose +4.58% in Tuesday, December 30, 2025's trading session, rising from a previous close of $0.41 to move at $0.43. The stock demonstrated notable intraday movement (see SGMO's key stats for a full breakdown), fluctuating between $0.40 and $0.43, a +7.62% trading range. While recent weeks have seen some volatility, SGMO has managed to secure a -2.89% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 5.66M shares changing hands, 19.05K fewer than the previous session. This amounted to $2.42M in total market activity.
Will SGMO Continue Its Upward Trend?
According to analyst ratings and projections for SGMO, Sangamo Therapeutics, Inc. shares are anticipated to increase by +7.12%, potentially reaching $0.46 per share by January 13, 2026. Short-term technical indicators currently suggest a neutral sentiment for SGMO. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the SGMO stock forecast, now is a good time to buy SGMO stock because its current trading price is +2.52% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on SGMO covering social and institutional perspectives.
SGMO Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into SGMO's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 43.66% to 43.80%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 45.16%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 46.51%, maintains a neutral outlook for the long term. Insights into SGMO's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Sangamo Therapeutics Short-Term Forecasts
SGMO Forecast For Next 5 Days
Our algorithm anticipates Sangamo Therapeutics (SGMO) stock could hit $0.38 by Jan 06, 2026. This represents a -11.42% fall from today's price, following a -7.15% change over the past five days.
SGMO Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Sangamo Therapeutics, Inc. (SGMO) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.35, which would mean a -18.09% decrease from the current price of $0.43. Projections for this period range from a high of $0.48 to a low of $0.21.
SGMO Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Sangamo Therapeutics's price over the next three months point to a rise. SGMO stock is expected to peak at $3.13 on Feb 04, 2026 before potentially dipping to $1.03 on Mar 31, 2026. On average, SGMO is likely to trade around $2.46 in the coming 90 days.
Sangamo Therapeutics Stock Forecast 2025
Based on our predictive models, Sangamo Therapeutics (SGMO) is expected to trade between $2.20 and $2.33 throughout 2025. This would result in an average price of $2.26, potentially offering investors a +428.90% return from current levels.
Sangamo Therapeutics, Inc. Monthly Forecast 2025–2026
December 2025
According to our latest forecast models, Sangamo Therapeutics, Inc. (SGMO) is positioned to show a strong performance in December 2025. The price is predicted to move between $2.20 and $2.33, settling at an average of $2.26. This could translate to a +428.90% gain.
January 2026
Based on current market signals, Sangamo Therapeutics, Inc. is projected to trend january 2026. We forecast a trading range from $2.04 to $3.01, with a likely average price of $2.39. Investors could expect a potential return of +459.33%.
February 2026
Our predictive algorithms indicate Sangamo Therapeutics, Inc. stock may see a shift in February 2026. The expected range spans $2.64–$3.13, with an average target of $2.90. This represents a positive outlook and a possible gain of +578.68%.
March 2026
Analyzing established trends, Sangamo Therapeutics, Inc. looks set to move in March 2026. Projections place the stock between $1.03 and $2.93, averaging around $2.15. This suggests a +403.16% gain from current levels.
April 2026
Market indicators suggest Sangamo Therapeutics, Inc. could experience notable changes during April 2026. Prices could fluctuate within $0.80 to $1.26, with a midpoint forecast of $1.17. The stock might deliver a +173.81% gain.
May 2026
Forecasting for May 2026, models estimate that Sangamo Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.61 and $1.34, averaging $1.28. This signals a positive trajectory with potential returns around +199.56%.
June 2026
According to our latest forecast models, Sangamo Therapeutics, Inc. (SGMO) is positioned to show a strong performance in June 2026. The price is predicted to move between $0.22 and $1.19, settling at an average of $1.09. This could translate to a +155.09% gain.
July 2026
Based on current market signals, Sangamo Therapeutics, Inc. is projected to trend july 2026. We forecast a trading range from $0.00 to $1.26, with a likely average price of $1.58. Investors could expect a potential return of +269.76%.
August 2026
Our predictive algorithms indicate Sangamo Therapeutics, Inc. stock may see a shift in August 2026. The expected range spans $0.00–$1.20, with an average target of $1.48. This represents a positive outlook and a possible gain of +246.36%.
September 2026
Analyzing established trends, Sangamo Therapeutics, Inc. looks set to move in September 2026. Projections place the stock between $0.00 and $0.49, averaging around $0.93. This suggests a +117.65% gain from current levels.
October 2026
Market indicators suggest Sangamo Therapeutics, Inc. could experience notable changes during October 2026. Prices could fluctuate within $0.00 to $0.24, with a midpoint forecast of $1.04. The stock might deliver a +143.39% gain.
November 2026
Forecasting for November 2026, models estimate that Sangamo Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.00, averaging $1.21. This signals a positive trajectory with potential returns around +183.17%.
December 2026
According to our latest forecast models, Sangamo Therapeutics, Inc. (SGMO) is positioned to show a strong performance in December 2026. The price is predicted to move between $0.00 and $0.00, settling at an average of $1.31. This could translate to a +206.58% gain.
SGMO's history of dividends and stock splits also plays a role in long-term investor confidence.

